title: [Transcatheter aortic valve implantation: results of a new therapeutic option for high surgical risk aortic stenosis].
abstract: BACKGROUND
  Transcatheter aortic valve implantation (TAVI) is an alternative to surgical aortic valve replacement in patients with severe aortic stenosis (AS) and unacceptably high surgical risk.
  
  
  METHODS
  We present our first two years' experience with TAVI. A total of 76 AS patients were evaluated for TAVI and 23 of them underwent a TAVI procedure. These patients had a mean EuroSCORE of 22.4% and a mean age of 81.5 years, and were prospectively followed for a mean of 12.9 ± 11 months.
  
  
  RESULTS
  The percutaneous aortic valve was successfully implanted in 100% of the patients. Mortality at 30 days was 4%. The most common complications were access site-related bleeding and transfusion (22%), followed by new permanent pacemaker implantation (9%). After a mean follow-up of 12.9 months, survival was 87%. In a maximum follow-up of 30 months there were no cases of prosthesis dysfunction or cardiovascular death.
  
  
  CONCLUSIONS
  Two years after the introduction of a TAVI program in our center, the procedure has established itself as a safe and effective alternative for patients with severe AS and unacceptably high surgical risk.
authors.affiliation: Serviço de Cardiologia, Hospital La Paz, Madrid, Espanha.
authors.forename: Pablo
authors.initials: P
authors.lastname: Salinas
authors.forename: Raul
authors.initials: R
authors.lastname: Moreno
authors.forename: Luis
authors.initials: L
authors.lastname: Calvo
authors.forename: David
authors.initials: D
authors.lastname: Dobarro
authors.forename: Santiago
authors.initials: S
authors.lastname: Jiménez-Valero
authors.forename: Angel
authors.initials: A
authors.lastname: Sánchez-Recalde
authors.forename: Guillermo
authors.initials: G
authors.lastname: Gaçeote
authors.forename: Luis
authors.initials: L
authors.lastname: Riera
authors.forename: Juan-Ignacio
authors.initials: JI
authors.lastname: González Montalvo
authors.forename: Ignacio
authors.initials: I
authors.lastname: Plaza
authors.forename: Francisco
authors.initials: F
authors.lastname: Mariscal
authors.forename: Rosa
authors.initials: R
authors.lastname: Gonzalez-Davia
authors.forename: Teresa
authors.initials: T
authors.lastname: López
authors.forename: Mar
authors.initials: M
authors.lastname: Moreno
authors.forename: Arturo
authors.initials: A
authors.lastname: Alvarez
authors.forename: Emilio
authors.initials: E
authors.lastname: Cuesta
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Garzon
authors.forename: David
authors.initials: D
authors.lastname: Filgueiras
authors.forename: Isidro
authors.initials: I
authors.lastname: Moreno-Gomez
authors.forename: Jose-María
authors.initials: JM
authors.lastname: Mesa
authors.forename: Jose-Luis
authors.initials: JL
authors.lastname: López-Sendon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001024:Aortic Valve Stenosis / Q000601:surgery*; D006328:Cardiac Catheterization; D005260:Female; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011474:Prosthesis Design; D012307:Risk Factors